Lexagene Holdings Inc. Brief: Up 21% Early Friday As BioPharma Engages It in Second Feasibility Study; LXG Cancels Plans to Reprice Meridian's Warrants
Lexagene Holdings Inc. Brief: Up 21% Early Friday As BioPharma Engages It in Second Feasibility Study; LXG Cancels Plans to Reprice Meridian's Warrants
LEXAGENE 控股有限公司簡介：上週五早些時候上漲 21％，因為生物製藥參與第二次可行性研究；LXG 取消計劃重新定價子午線的權證
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊